A study, co-led by Rebecca Fitzgerald (MRC Cancer Unit and CRUK Cambridge Centre Early Detection Programme), has developed a statistical model that uses genomic data to predict the risk of developing cancer of the oesophagus up to eight years before diagnosis. Published in Nature Medicine, the researchers analysed DNA from tissue biopsies taken from patients […]
A study, led by Julian Rayner and Michael Weekes (both Cambridge Institute for Medical Research), in collaboration with scientists at the Wellcome Sanger Institute, the Cavendish Laboratory and the KEMRI-Wellcome Trust Research Programme in Kenya, has identified how the Dantu genetic blood variant helps to protect against malaria. Malaria remains a major global health problem […]
The DIRECT study is a molecular profiling study for patients with diffuse large B cell lymphoma (DLBCL) and closely related aggressive lymphomas. DLBCL is the commonest haematological malignancy with over 4,500 cases annually in the UK. Patients with DLBCL will be recruited from Addenbrooke’s Hospital and four other UK teaching hospitals. The Cancer Molecular Diagnostics […]
NOW – a Crowdfunding campaign to connect scientific research to the world of patients by supporting four cancer patients’ associations. Scientific research is essential for the well-being of society, but quite often it takes many years to collect the results from our research with no immediate effect on the patients. The timing of research and […]
Cancer cells are surrounded by a diverse range of “normal cells” known as the stroma. The stroma includes immune cells, endothelial cells, fibroblasts and the extracellular matrix scaffold they produce. Together cancer cells and stroma form the tumour microenvironment. Crosstalk between the tumour and stroma is critical to help a tumour form and grow, but […]
One of Cambridge’s newest institutes, established to study the relationship between infectious disease and our immune systems, is leading the University of Cambridge’s response to the COVID-19 pandemic, with over 150 scientists and clinicians, the UK’s largest academic Containment Level 3 Facility, and a range of collaborators from across the UK and beyond.